Access brought to you by: LOCKSS

Hyperglycemia/Hypoglycemia

Mechanisms Underlying Cardiovascular Disease in Diabetes Mellitus
Significant HbA_1c Reduction With Empagliflozin/Linagliptin Combination
Optimal Dosing and Titration of U-500R Improve Glycemic Control
Dulaglutide Noninferior to Liraglutide for Glycemic Control in Patients with T2DM
Dulaglutide Reduces HbA_1c More Than Glargine When Used in Combination with Prandial Insulin
Structured Education and Appropriate Pharmacologic Intervention in a Day Clinic Improves Glycemic Control in Adult Patients with Diabetes
Exenatide Increases Glucose Uptake in Brain Areas Involved in Glucose Homeostasis and Food Intake
IDegLira Offers Advantages over IDeg and Liraglutide in T2DM: DUAL I Results
Once Weekly Exenatide is Safe and Effective for Long-term T2DM Treatment
GLUCO-CABG: No Reduction in Perioperative Complications to Cardiac Surgery with Intensive Control of Hyperglycemia

Pages